Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Biota Pharmaceuticals Inc    NABI

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Operates as an anti-infective drug development company

Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections.

Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics, currently being evaluated in ongoing Phase 2b SPIRITUS trial; BTA074, a Phase 2 topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor in Phase 1 development for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment in Phase 2 development for influenza A and B infections.

The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA.
Managers
NameAgeSinceTitle
Joseph M. Patti, PhD532012President, CEO & Executive Director
Russell H. Plumb MBA, CPA582012Executive Chairman
Mark P. Colonnese MBA, CPA612015Chief Financial Officer & Executive Vice President
John H. Vernachio, PhD-2014Vice President-Preclinical Development
Geoffrey F. Cox, PhD732012Independent Non-Executive Director
Anne M. VanLent692013Lead Independent Non-Executive Director
Michael R. Dougherty592013Independent Non-Executive Director
John P. Richard, MBA592013Independent Non-Executive Director
Armando Anido, MBA592015Independent Non-Executive Director
Michael W. Dunne, MD572015Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 38,640,487 34,873,116 90.3% 0 0.0% 90.3%
Shareholders
NameEquities%
Broadfin Capital LLC 3,486,711 9.02%
East Hill Management Co. LLC 3,456,520 8.95%
Krensavage Asset Management LLC 2,713,517 7.02%
Senzar Asset Management LLC 1,779,976 4.61%
The Vanguard Group, Inc. 1,044,243 2.70%
Renaissance Technologies LLC 665,158 1.72%
BlackRock Fund Advisors 588,061 1.52%
Fidelity Management & Research Co. 390,000 1.01%
Stonepine Capital Management LLC 347,440 0.90%
Landon Thomas Clay 327,672 0.85%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
BIOTA PHARMACEUTICALS ..48
AMGEN, INC.4.45%113 612
GILEAD SCIENCES, INC.-1.28%93 131
CELGENE CORPORATION-2.97%87 063
REGENERON PHARMACEUTIC..-3.47%37 374
ACTELION LTD1.18%24 865
VERTEX PHARMACEUTICALS..10.49%20 190
GENMAB A/S6.56%11 103
TESARO INC8.63%7 802
EXELIXIS, INC.22.67%5 239
ARIAD PHARMACEUTICALS,..90.59%4 605
HUALAN BIOLOGICAL ENGI..--.--%4 577
TONGHUA DONGBAO PHARMA..-5.20%4 310
NEUROCRINE BIOSCIENCES..0.36%3 374
CHINA BIOLOGIC PRODUCT..3.43%3 018
BIOCON LTD2.80%2 929
PEPTIDREAM INC-5.43%2 910
ULTRAGENYX PHARMACEUTI..-2.29%2 794
BLUEBIRD BIO INC5.92%2 652
INTERCEPT PHARMACEUTIC..1.37%2 610
CLOVIS ONCOLOGY INC32.44%2 608
Sector Bio Therapeutic Drugs
Biota Pharmaceuticals Inc : Connections
Phase4 Partners Ltd.
Beacon Street Advisors LLC
Massachusetts Biotechnology Council
International AIDS Vaccine Initiative, Inc.
AMV Advisors
Pennsylvania Biotechnology Association
Altiris Therapeutics, Inc.
QUE Oncology, Inc.
Georgia Venture Partners LLC
Zygogen LLC
Shire ViroPharma, Inc.
Lakewood-Amedex, Inc.
Cempra Pharmaceuticals, Inc.
SciStem Therapeutics, Inc.
Axotect, Inc.
Altherx, Inc.
Iterum Pharmaceuticals LLC
Company contact information
Aviragen Therapeutics, Inc.
2500 Northwinds Parkway
Suite 100
Alpharetta, GA 30009

Phone : +1.678.221.3343
Web : www.aviragen.com
© 2017 People , Fundamentals and Ownership